Literature DB >> 24900233

Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac Myosin.

Bradley P Morgan1, Alexander Muci1, Pu-Ping Lu1, Xiangping Qian1, Todd Tochimoto1, Whitney W Smith1, Marc Garard1, Erica Kraynack1, Scott Collibee1, Ion Suehiro1, Adam Tomasi1, S Corey Valdez1, Wenyue Wang1, Hong Jiang1, James Hartman1, Hector M Rodriguez1, Raja Kawas1, Sheila Sylvester1, Kathleen A Elias1, Guillermo Godinez1, Kenneth Lee1, Robert Anderson1, Sandra Sueoka1, Donghong Xu1, Zhengping Wang1, Nebojsa Djordjevic1, Fady I Malik1, David J Morgans1.   

Abstract

We report the design, synthesis, and optimization of the first, selective activators of cardiac myosin. Starting with a poorly soluble, nitro-aromatic hit compound (1), potent, selective, and soluble myosin activators were designed culminating in the discovery of omecamtiv mecarbil (24). Compound 24 is currently in clinical trials for the treatment of systolic heart failure.

Entities:  

Keywords:  Omecamtiv mecarbil; cardiac myosin; small molecule enzyme activator; systolic heart failure

Year:  2010        PMID: 24900233      PMCID: PMC4007828          DOI: 10.1021/ml100138q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  16 in total

1.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

Authors:  R S Obach
Journal:  Drug Metab Dispos       Date:  1999-11       Impact factor: 3.922

Review 2.  High-performance affinity chromatography: a powerful tool for studying serum protein binding.

Authors:  David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-02-25       Impact factor: 3.205

3.  6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.

Authors:  S M Bromidge; M Duckworth; I T Forbes; P Ham; F D King; K M Thewlis; F E Blaney; C B Naylor; T P Blackburn; G A Kennett; M D Wood; S E Clarke
Journal:  J Med Chem       Date:  1997-10-24       Impact factor: 7.446

4.  Chromatographic analysis of carbamazepine binding to human serum albumin. II. Comparison of the Schiff base and N-hydroxysuccinimide immobilization methods.

Authors:  Hee Seung Kim; Rangan Mallik; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-05-09       Impact factor: 3.205

5.  Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.

Authors:  S M Bromidge; S Dabbs; D T Davies; S Davies; D M Duckworth; I T Forbes; L M Gaster; P Ham; G E Jones; F D King; K R Mulholland; D V Saunders; P A Wyman; F E Blaney; S E Clarke; T P Blackburn; V Holland; G A Kennett; S Lightowler; D N Middlemiss; B Trail; G J Riley; M D Wood
Journal:  J Med Chem       Date:  2000-03-23       Impact factor: 7.446

6.  Chromatographic analysis of carbamazepine binding to human serum albumin.

Authors:  Hee Seung Kim; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-02-25       Impact factor: 3.205

7.  Synthesis and structure-activity relationships of trisubstituted phenyl urea derivatives as neuropeptide Y5 receptor antagonists.

Authors:  C Fotsch; J D Sonnenberg; N Chen; C Hale; W Karbon; M H Norman
Journal:  J Med Chem       Date:  2001-07-05       Impact factor: 7.446

8.  Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.

Authors:  You-Tang Shen; Fady I Malik; Xin Zhao; Christophe Depre; Sunil K Dhar; Patricio Abarzúa; David J Morgans; Stephen F Vatner
Journal:  Circ Heart Fail       Date:  2010-05-24       Impact factor: 8.790

9.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Authors:  M Packer; J R Carver; R J Rodeheffer; R J Ivanhoe; R DiBianco; S M Zeldis; G H Hendrix; W J Bommer; U Elkayam; M L Kukin
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

10.  The hydrolysis of amides and the proficiency of amidohydrolases. The burden borne by kw.

Authors:  Guillermina Estiu; Kenneth M Merz
Journal:  J Phys Chem B       Date:  2007-05-18       Impact factor: 2.991

View more
  31 in total

1.  Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.

Authors:  Fady I Malik; James J Hartman; Kathleen A Elias; Bradley P Morgan; Hector Rodriguez; Katjusa Brejc; Robert L Anderson; Sandra H Sueoka; Kenneth H Lee; Jeffrey T Finer; Roman Sakowicz; Ramesh Baliga; David R Cox; Marc Garard; Guillermo Godinez; Raja Kawas; Erica Kraynack; David Lenzi; Pu Ping Lu; Alexander Muci; Congrong Niu; Xiangping Qian; Daniel W Pierce; Maria Pokrovskii; Ion Suehiro; Sheila Sylvester; Todd Tochimoto; Corey Valdez; Wenyue Wang; Tatsuo Katori; David A Kass; You-Tang Shen; Stephen F Vatner; David J Morgans
Journal:  Science       Date:  2011-03-18       Impact factor: 47.728

2.  Synthesis of unsymmetrical diarylureas via Pd-catalyzed C-N cross-coupling reactions.

Authors:  Simon Breitler; Nathan J Oldenhuis; Brett P Fors; Stephen L Buchwald
Journal:  Org Lett       Date:  2011-05-23       Impact factor: 6.005

Review 3.  Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

Authors:  Miguel Pinilla-Vera; Virginia S Hahn; David A Kass
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

4.  A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors.

Authors:  Laszlo Radnai; Rebecca F Stremel; James R Sellers; Gavin Rumbaugh; Courtney A Miller
Journal:  J Vis Exp       Date:  2019-08-17       Impact factor: 1.355

Review 5.  Novel drug mechanisms in development for heart failure.

Authors:  Soidjon D Khodjaev; John R Teerlink; Fady I Malik
Journal:  Pflugers Arch       Date:  2014-05-06       Impact factor: 3.657

6.  Palladium-catalyzed cross-coupling of aryl chlorides and triflates with sodium cyanate: a practical synthesis of unsymmetrical ureas.

Authors:  Ekaterina V Vinogradova; Brett P Fors; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2012-06-29       Impact factor: 15.419

7.  AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.

Authors:  Stephen C Kolwicz; Guy L Odom; Sarah G Nowakowski; Farid Moussavi-Harami; Xiaolan Chen; Hans Reinecke; Stephen D Hauschka; Charles E Murry; Gregory G Mahairas; Michael Regnier
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

Review 8.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

Review 9.  Force generation by kinesin and myosin cytoskeletal motor proteins.

Authors:  F Jon Kull; Sharyn A Endow
Journal:  J Cell Sci       Date:  2013-03-13       Impact factor: 5.285

Review 10.  New medical therapies for heart failure.

Authors:  Thomas G von Lueder; Henry Krum
Journal:  Nat Rev Cardiol       Date:  2015-09-29       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.